UBS ETFPlease confirm you are resident in Italy to proceed.

Risk information

In addition to the usual risks referring to market fluctuations, securities and index type, the investor has to be aware that the funds detailed in this document are also exposed to other risks, such as: secondary market negotiations, differences between NAV and market prices, calculation changes, differences in publications of the index on behalf of the index provider, risks connected to the listing of the index components on different markets, risks connected to the use of derivatives.

There are also further risks these funds that replicate equity or bond indexes are exposed to. The investor is therefore required to have an adequate tolerance and capacity to bear such risks.

For a complete analysis of all the risks described we recommend to read carefully the prospectus.

Reset

ETF Comparison

UBS ETF (IE) MSCI China A SF UCITS ETF (USD) A-acc

ISIN IE00BKFB6K94
Replication Synthetic
Asset class Equities
Fee 0.30%
Change

Select a fund for comparison

Select
General information

Name of fund

UBS (Irl) Fund Solutions plc – MSCI China A SF UCITS ETF

Share class

UBS (Irl) Fund Solutions plc – MSCI China A SF UCITS ETF (USD) A-acc

ISIN

IE00BKFB6K94

Asset Class

Equities

Fund domicile

IE

Fund type

open-end

Benchmark

MSCI China A Total Return Net Index

UCITS V

yes

Launch date

18.02.2020

Currency of share class

USD

Accounting year end

30 June

Replication methodology

Synthetic (Fully Funded + Total Return Swap)

Fund description
  • The investment objective of the fund is to deliver the net total return performance of the MSCI China A Index less costs.
  • The Fund replicates synthetically the index performance by investing in a swap.
  • The swap counterparty transfers collateral to the ETF in the form of G10 government bonds, supranational bonds and cash.
  • The fund is passively managed.
  • The product described herein aligns to Article 6 of Regulation (EU) 2019/2088.
Fees

Flat fee p.a.

0.30%

Total expense ratio (TER) p.a.1)

0.30%

Index description
  • The Reference Index captures large and mid-cap representation across China securities listed on the Shanghai and Shenzhen exchanges. The index covers only those securities that are accessible through "Stock Connect" (a unique collaboration between the Hong Kong, Shanghai and Shenzhen Stock Exchanges, Stock Connect allows international and Mainland Chinese investors to trade securities in each other's markets through the trading and clearing facilities of their home exchange). The index is calculated using China A Stock Connect listings based on the offshore RMB exchange rate (CNH). The Reference Index is based on the MSCI Global Investable Market Indexes (GIMI).

Please consider that this performance comparison tool serves for illustration purposes only as it allows to compare any UBS ETF regardless its fund characteristics, investment objectives. Please note that certain comparisons might be insignificant or misleading due to markets, currencies, sectors or risk exposures that might not be comparable. Neither UBS AG nor any of its affiliates, its directors, employees or agents accepts any liability for any loss or damage arising out of the use of this tool.

For information and marketing purposes from UBS. UBS Funds under Luxembourg law. Representative in Italy for UBS funds, UBS Asset Management (Italia) SGR S.p.A., Via del Vecchio Politecnico, 3 Milano where the prospectus, the KIID, as well as the Articles of Association for UBS SICAVs and the latest annual or semi-annual report may be obtained free of charge. Before investing in any product read carefully the last prospectus. Units of UBS funds mentioned in the presentation may not be offered, sold or assigned in the United States. The information here disclosed is not intended to be a solicitation or an offer to purchase or sell any securities or related financial instrument. Please note that past performance is not a guide to the future. Past performance do not consider any commission or costs debited at the subscription or redemption. Costs and fees negatively impact on performance. If the currency of a product or a financial service differs from your currency, returns may vary depending on currency fluctuations. This document has been drafted without particular reference to specific or future investment objectives or to financial or tax situation or to specific needs of a specific addressee. As individual situations may differ, clients should seek independent professional tax, legal, accounting or other specialist advisors as to the legal and tax implication of investing. Information and opinions are delivered without any guarantee or warranty by UBS, exclusively per information and personal use.
This document contains statements that constitute "forward-looking statements", including, but not limited to, statements relating to our future business development. While these forward-looking statements represent our judgments and future expectations concerning the development of our business, a number of risks, uncertainties and other important factors could cause actual developments and results to differ materially from our expectations. All information and opinions are subject to change without notice. Information do not reflect regulatory requirements aimed at promoting the independence of financial research. Information is not subject to any trading prohibition before publication. UBS AG and / or other members of the UBS Group may have a position in and may make a purchase and / or sale of any of the securities or other financial instruments mentioned in this document. Source for all data and charts (if not indicated otherwise): UBS Asset Management.
© UBS 2022. The key symbol and UBS are among the registered and unregistered trademarks of UBS. All rights reserved.